Neuss Michael, Gilmore Terry, Belderson Kristin, Billett Amy, Conti-Kalchik Tara, Harvey Brittany, Hendricks Carolyn, LeFebvre Kristine, Mangu Pamela, McNiff Kristen, Olsen MiKaela, Schulmeister Lisa, Von Gehr Anne, Polovich Martha
Oncol Nurs Forum. 2017 Jan 6;44(1):31-43. doi: 10.1188/17.ONF.31-43.
To update the American Society of Clinical Oncology (ASCO)/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology.
The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology Nurses and American Society of Pediatric Hematology/Oncology, was held on May 12, 2015, to review the 2013 standards. An extensive literature search was subsequently conducted, and public comments on the revised draft standards were solicited.
The updated 2016 standards presented here include clarification and expansion of existing standards to include pediatric oncology and to introduce new standards: most notably, two-person verification of chemotherapy preparation processes, administration of vinca alkaloids via minibags in facilities in which intrathecal medications are administered, and labeling of medications dispensed from the health care setting to be taken by the patient at home. The standards were reordered and renumbered to align with the sequential processes of chemotherapy prescription, preparation, and administration. Several standards were separated into their respective components for clarity and to facilitate measurement of adherence to a standard.
As oncology practice has changed, so have chemotherapy administration safety standards. Advances in technology, cancer treatment, and education and training have prompted the need for periodic review and revision of the standards. Additional information is available at http://www.asco.org/chemo-standards.
更新美国临床肿瘤学会（ASCO）/肿瘤护理学会（ONS）化疗给药安全标准，并突出儿科肿瘤学的标准。
ASCO/ONS化疗给药安全标准于2009年首次发布，并于2011年更新以纳入住院环境。随后在2013年的修订版中扩大了标准范围，纳入了口服化疗的安全给药和管理。2015年5月12日举行了一次由利益相关者参与的ASCO/ONS联合研讨会，包括儿科血液肿瘤护士协会和美国儿科血液学/肿瘤学会，以审查2013年的标准。随后进行了广泛的文献检索，并征求了对修订草案标准的公众意见。
此处呈现的2016年更新标准包括对现有标准的澄清和扩展，以纳入儿科肿瘤学并引入新的标准：最显著的是，化疗准备过程的双人核对、在进行鞘内给药的设施中通过小袋输注长春花生物碱，以及对医疗机构分发的供患者在家服用的药物进行标签标注。这些标准重新排序并重新编号，以与化疗处方、准备和给药的顺序流程保持一致。为了清晰起见并便于衡量对标准的遵守情况，几个标准被分成了各自的组成部分。
随着肿瘤学实践的变化，化疗给药安全标准也发生了变化。技术、癌症治疗以及教育和培训的进步促使需要定期审查和修订这些标准。更多信息可在http://www.asco.org/chemo-standards获取。
